Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015).
about
Probing protein flexibility reveals a mechanism for selective promiscuity.Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses.Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer.Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells.Global patent landscape of programmed cell death 1: implications of the rapid expansion.Bioactive Macrocyclic Inhibitors of the PD-1/PD-L1 Immune Checkpoint.
P2860
Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015).
@en
type
label
Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015).
@en
prefLabel
Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015).
@en
P2093
P2860
P1476
Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015).
@en
P2093
Dobroslawa Krzemien
Krzysztof Zak
Markella Konstantinidou
Tad A Holak
Tryfon Zarganes-Tzitzikas
Yongzhi Gao
P2860
P304
P356
10.1080/13543776.2016.1206527
P407
P577
2016-07-01T00:00:00Z